{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:17:55Z","timestamp":1787883475590,"version":"build-2784847793"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Limited granular data exist on breast cancer in transgender, nonbinary, and\/or gender-diverse (TGD) individuals.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To describe patient demographic and tumor clinicopathological variables, clinically relevant risk factors, method of breast cancer detection, treatment characteristics, and locoregional outcomes and to estimate a 5-year breast cancer\u2013specific survival (BCSS).<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cohort study obtained data on patients treated from 1990 to 2023 from 22 US academic medical centers using institutional databases, electronic medical records, and tumor registries. Included participants were TGD individuals 18 years or older with stage 0 to IV breast cancer. A comparative breast cancer cohort was selected from the 2016 to 2021 Surveillance, Epidemiology, and End Results Program (SEER) breast cancer dataset. Data were analyzed from January to October 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Breast cancer.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n \n Estimated 5-year BCSS and locoregional recurrence rates. Wilcoxon rank sum and \u03c7\n 2<\/jats:sup>\n tests were used to compare continuous and categorical variables. Kaplan-Meier analysis was used to estimate 5-year BCSS.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 112 TGD persons (median [IQR] age at diagnosis, 42.5 [36.5-51.0] years; 104 individuals [92.9%] were assigned female at birth) with breast cancer and 1 with bilateral disease were included in the analysis. Forty-three patients (38.4%) used gender-affirming hormone therapy before diagnosis. Among the entire cohort, 58 patients (51.8%) detected their own breast cancer, 68 (60.7%) had a familial breast cancer history, and 16 (14.3%) had a pathogenic germline variant. Tumors were predominantly hormone receptor positive (96 [85.7%]) and early stage (29 [25.7%] ductal carcinoma in situ [DCIS]; 51 [45.1%] stage I). The TGD cohort, compared with patients with breast cancer in the SEER dataset (N\u2009=\u2009480\u202f915), was younger (median [IQR] age, 42.5 [36.5-51.0] years vs 62.0 [52.0-72.0] years), had a higher proportion of persons assigned male at birth (8 [7.1%] vs 3522 [0.7%]), more often had progesterone receptor\u2013positive disease (89 [79.5%] vs 335 491 [69.8%]), and presented with earlier-stage disease (eg, DCIS: 29 [25.9%] vs 79 604 [16.6%]). With a median (IQR) follow-up time for the TGD cohort of 38 (24-74) months, 5-year BCSS was favorable at 96.2% (95% CI, 85.3%-99.0%).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This cohort study of TGD patients with breast cancer found that this population was young and often detected their own tumors via self-examination, suggesting opportunities to improve early detection through screening for individuals at elevated risk. Although short-term BCSS appeared favorable, prospective research is essential to define evidence-based guidelines and elucidate long-term outcomes.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.24824","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:30:34Z","timestamp":1784820634000},"page":"e2624824","source":"Crossref","is-referenced-by-count":1,"title":["Characteristics of Gender-Diverse Patients With Breast Cancer"],"prefix":"10.1001","volume":"9","author":[{"given":"Chandler S.","family":"Cortina","sequence":"first","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee"},{"name":"Medical College of Wisconsin Cancer Center, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruta","family":"Brazauskas","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan R.","family":"Flanagan","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Washington, Seattle"},{"name":"Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington"},{"name":"University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen D.","family":"Dill","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathie-Ann P.","family":"Joseph","sequence":"additional","affiliation":[{"name":"Departments of Surgery and Population Health, New York University (NYU) Grossman School of Medicine\/NYU Langone Health, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr","family":"Trifonov","sequence":"additional","affiliation":[{"name":"LGBTQ+ Care and Research Program, NYU Langone Perlmutter Cancer Center, NYU Grossman School of Medicine, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita A.","family":"Mukhtar","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, University of California San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther A.","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Plastic Surgery, Department of Surgery, University of California San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kantor","sequence":"additional","affiliation":[{"name":"Department of Surgery, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabi","family":"Barmettler","sequence":"additional","affiliation":[{"name":"Department of Surgery, Brigham and Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen M.","family":"Rezak","sequence":"additional","affiliation":[{"name":"Division of Plastic, Maxillofacial, and Oral Surgery, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura H.","family":"Rosenberger","sequence":"additional","affiliation":[{"name":"Department of Surgery, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumanas W.","family":"Jordan","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Department of Surgery, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M.","family":"Perez","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Department of Surgery, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel B.","family":"Jimenez","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia C.","family":"Smart","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Massachusetts General Hospital, Boston"},{"name":"Department of Radiation Oncology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Kopkash","sequence":"additional","affiliation":[{"name":"Department of Surgery, Northshore University HealthSystem, Evanston, Illinois"},{"name":"University of Chicago Pritzker School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasha M.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine C.","family":"Walker","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meeghan A.","family":"Lautner","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L.","family":"Siegel","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle E.","family":"Brabender","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahraa","family":"Al-Hilli","sequence":"additional","affiliation":[{"name":"Breast Center, Integrated Surgical Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Cassidy","sequence":"additional","affiliation":[{"name":"Section of Surgical Oncology Department of Surgery, Boston University Chobanian and Avedisian School of Medicine Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Rochester, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"McCaffrey","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie C.","family":"Lee","sequence":"additional","affiliation":[{"name":"Comprehensive Breast Program, Moffitt Cancer Center, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christodoulos","family":"Kaoutzanis","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khoa N.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine, University of Colorado\u2013Denver, Anschutz Medical Campus, Denver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer D.","family":"Son","sequence":"additional","affiliation":[{"name":"Department of Surgery, MedStar Montgomery and MedStar Georgetown University Hospital, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin D.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Madrigrano","sequence":"additional","affiliation":[{"name":"Department of Surgery, Rush University Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"McLaughlin","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Petroll","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Department of Medicine, Medical College of Wisconsin, Milwaukee"},{"name":"Froedtert and the Medical College of Wisconsin Inclusion Health Clinic, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Stolley","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin Cancer Center, Milwaukee"},{"name":"Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"8","key":"zoi260694r2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.30348","article-title":"National estimates of gender-affirming surgery in the US.","volume":"6","author":"Wright","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"7","key":"zoi260694r3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jamasurg.2021.0952","article-title":"Association between gender-affirming surgeries and mental health outcomes.","volume":"156","author":"Almazan","year":"2021","journal-title":"JAMA Surg"},{"issue":"8","key":"zoi260694r4","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41562-023-01605-w","article-title":"A systematic review of psychosocial functioning changes after gender-affirming hormone therapy among transgender people.","volume":"7","author":"Doyle","year":"2023","journal-title":"Nat Hum Behav"},{"issue":"8","key":"zoi260694r5","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1001\/jamaoncol.2022.1638","article-title":"Inclusion and reporting of transgender and nonbinary persons in clinical trials and tumor registries-the time is now.","volume":"8","author":"Cortina","year":"2022","journal-title":"JAMA Oncol"},{"issue":"4","key":"zoi260694r6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142029","article-title":"Research gaps in medical treatment of transgender\/nonbinary people.","volume":"131","author":"Safer","year":"2021","journal-title":"J Clin Invest"},{"issue":"1","key":"zoi260694r7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10549-014-3213-2","article-title":"Incidence of breast cancer in a cohort of 5,135 transgender veterans.","volume":"149","author":"Brown","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"zoi260694r8","doi-asserted-by":"publisher","first-page":"l1652","DOI":"10.1136\/bmj.l1652","article-title":"Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.","volume":"365","author":"de Blok","year":"2019","journal-title":"BMJ"},{"issue":"9","key":"zoi260694r9","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/jnci\/djab028","article-title":"Cancer stage, treatment, and survival among transgender patients in the United States.","volume":"113","author":"Jackson","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"zoi260694r10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1001\/jamaoncol.2022.7146","article-title":"Breast cancer diagnosis, treatment, and outcomes of patients from sex and gender minority groups.","volume":"9","author":"Eckhert","year":"2023","journal-title":"JAMA Oncol"},{"issue":"7","key":"zoi260694r11","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/jamaoncol.2025.1138","article-title":"Breast cancer outcomes in transgender and gender-diverse patients in the National Cancer Database.","volume":"11","author":"Chan","year":"2025","journal-title":"JAMA Oncol"},{"issue":"9596","key":"zoi260694r12","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"zoi260694r13","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1245\/s10434-021-10217-5","article-title":"Breast cancer risk and screening in transgender persons: a call for inclusive care.","volume":"29","author":"Clarke","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"zoi260694r14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s12609-025-00573-6","article-title":"Contemporary considerations for breast cancer risk and screening in transgender, nonbinary, and gender-diverse populations.","volume":"17","author":"Huynh","year":"2025","journal-title":"Curr Breast Cancer Rep"},{"key":"zoi260694r15","doi-asserted-by":"publisher","DOI":"10.1177\/17455057241289706","article-title":"Breast care considerations for transgender and gender-diverse patients.","volume":"20","author":"Carroll","year":"2024","journal-title":"Womens Health (Lond)"},{"issue":"11","key":"zoi260694r18","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline.","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"zoi260694r19","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1136\/ijgc-2020-001860","article-title":"Transgender patients: considerations for routine gynecologic care and cancer screening.","volume":"30","author":"Labanca","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"zoi260694r20","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"key":"zoi260694r21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12609-020-00403-x","article-title":"Breast cancer risk and screening in transgender individuals.","volume":"13","author":"Roznovjak","year":"2021","journal-title":"Curr Breast Cancer Rep"},{"issue":"11S","key":"zoi260694r22","doi-asserted-by":"publisher","first-page":"S502","DOI":"10.1016\/j.jacr.2021.09.005","article-title":"ACR Appropriateness Criteria\u00ae transgender breast cancer screening.","volume":"18","author":"Brown","year":"2021","journal-title":"J Am Coll Radiol"},{"issue":"3","key":"zoi260694r23","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1245\/s10434-021-10932-z","article-title":"A single-center study of adherence to breast cancer screening mammography guidelines by transgender and non-binary patients.","volume":"29","author":"Luehmann","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"zoi260694r24","doi-asserted-by":"publisher","first-page":"e794","DOI":"10.1200\/OP.22.00681","article-title":"Perceptions of transgender and nonbinary persons toward breast and cervical cancer development, screening, and potential impact on gender-affirming hormone therapy.","volume":"19","author":"Roznovjak","year":"2023","journal-title":"JCO Oncol Pract"},{"issue":"9","key":"zoi260694r25","doi-asserted-by":"publisher","first-page":"5560","DOI":"10.1245\/s10434-024-15319-4","article-title":"Tumors, treatments, and trust: cancer characteristics, outcomes, and screening uptake in transgender and gender-diverse patients.","volume":"31","author":"Istl","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"zoi260694r26","doi-asserted-by":"publisher","first-page":"6978","DOI":"10.1245\/s10434-023-14195-8","article-title":"Current insurance policy coverage for screening mammography in transgender and gender-diverse individuals.","volume":"30","author":"Cortina","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"zoi260694r27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1001\/jamasurg.2022.5447","article-title":"Assessing breast and ovarian cancer risk prior to gender-affirming surgery.","volume":"158","author":"Cortina","year":"2023","journal-title":"JAMA Surg"},{"issue":"1","key":"zoi260694r28","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00545-9","article-title":"Chest mass in a transgender man after top surgery.","volume":"24","author":"Cortina","year":"2023","journal-title":"Lancet Oncol"},{"issue":"11","key":"zoi260694r29","doi-asserted-by":"publisher","first-page":"7474","DOI":"10.1245\/s10434-024-15701-2","article-title":"The impact of a breast cancer risk assessment on the decision for gender-affirming chest masculinization surgery in transgender and gender-diverse individuals: a pilot single-arm educational intervention trial.","volume":"31","author":"Cortina","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"zoi260694r30","doi-asserted-by":"publisher","first-page":"7483","DOI":"10.1245\/s10434-024-15801-z","article-title":"ASO Author Reflections: a breast cancer risk assessment and the decision for gender-affirming chest masculinization surgery or oncologic risk-reducing mastectomies in transgender and gender-diverse individuals.","volume":"31","author":"Cortina","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"zoi260694r31","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/his.13299","article-title":"Clinicopathological findings in female-to-male gender-affirming breast surgery.","volume":"71","author":"East","year":"2017","journal-title":"Histopathology"},{"issue":"12","key":"zoi260694r32","doi-asserted-by":"publisher","first-page":"8086","DOI":"10.1245\/s10434-024-16005-1","article-title":"Incidence of high risk and malignant pathological findings in transgender and gender diverse individuals undergoing gender-affirming mastectomy.","volume":"31","author":"McCaffrey","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"zoi260694r33","doi-asserted-by":"publisher","first-page":"S148","DOI":"10.1097\/SAP.0000000000003175","article-title":"Transgender mastectomy: incidence of high-risk pathologic findings and the need for postoperative cancer surveillance.","volume":"88","author":"Bruce","year":"2022","journal-title":"Ann Plast Surg"},{"issue":"1","key":"zoi260694r34","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/PRS.0000000000007452","article-title":"Incidence of cancer and premalignant lesions in surgical specimens of transgender patients.","volume":"147","author":"Jacoby","year":"2021","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"zoi260694r35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13058-024-01867-w","article-title":"Effect of testosterone therapy on breast tissue composition and mammographic breast density in trans masculine individuals.","volume":"26","author":"Heng","year":"2024","journal-title":"Breast Cancer Res"},{"issue":"1","key":"zoi260694r36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3322\/caac.21872","article-title":"Cancer care for transgender and gender-diverse people: practical, literature-driven recommendations from the Multinational Association of Supportive Care in Cancer.","volume":"75","author":"Cathcart-Rake","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"20","key":"zoi260694r37","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1200\/JCO.22.01857","article-title":"Why good cancer care means gender-affirming care for transgender individuals with gendered cancers: implications for research, policy, and practice.","volume":"41","author":"Bybee","year":"2023","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi260694r38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mayocp.2024.10.002","article-title":"Gender-affirming hormone therapy for breast cancer in transgender and gender-diverse individuals: unresolved and unaddressed issues.","volume":"100","author":"Rajput","year":"2025","journal-title":"Mayo Clin Proc"},{"key":"zoi260694r39","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2024.107913","article-title":"Breast cancer and gender-affirming hormone therapy for transgender and gender-diverse (TGD) individuals.","volume":"181","author":"Cathcart-Rake","year":"2024","journal-title":"Maturitas"},{"issue":"4","key":"zoi260694r40","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.4708","article-title":"Development and assessment of a patient-reported outcome instrument for gender-affirming care.","volume":"8","author":"Kaur","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi260694r41","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s41687-024-00785-x","article-title":"International study to develop a patient-reported outcome measure to evaluate outcomes of gender-affirming care\u2014the GENDER-Q.","volume":"8","author":"Kaur","year":"2024","journal-title":"J Patient Rep Outcomes"},{"issue":"2","key":"zoi260694r42","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/PRS.0b013e3181aee807","article-title":"Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q.","volume":"124","author":"Pusic","year":"2009","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"zoi260694r43","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa2005936","article-title":"A population-based study of genes previously implicated in breast cancer.","volume":"384","author":"Hu","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi260694r45","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/andr.13181","article-title":"Gender affirming hormonal treatment in Danish transgender persons: a nationwide register-based study.","volume":"10","author":"Glintborg","year":"2022","journal-title":"Andrology"},{"key":"zoi260694r17","volume-title":"Medical Care of Trans and Gender Diverse Adults","author":"Thompson","year":"2021"},{"key":"zoi260694r1","unstructured":"Flores? AR, Conron? KJ, Herman? JL. How many adults and youth identify as transgender in the United States? The Williams Institute, UCLA School of Law. August 2025. Accessed September 11, 2025. https:\/\/williamsinstitute.law.ucla.edu\/publications\/trans-adults-united-states\/"},{"key":"zoi260694r16","unstructured":"Deutsch? MB, ed. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people. 2nd ed. UCSF Gender Affirming Health Program, Department of Family and Community Medicine, University of California San Francisco. 2016. Accessed September 11, 2025. https:\/\/transcare.ucsf.edu\/guidelines"},{"key":"zoi260694r44","unstructured":"Brown? A. About 5% of young adults in the U.S. say their gender is different from their sex assigned at birth. Pew Research Center. June 7, 2022. Accessed September 30, 2025. https:\/\/www.pewresearch.org\/short-reads\/2022\/06\/07\/about-5-of-young-adults-in-the-u-s-say-their-gender-is-different-from-their-sex-assigned-at-birth\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2851975\/cortina_2026_oi_260694_1787321198.08782.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:00:19Z","timestamp":1787842819000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2851975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.24824","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}